ID

23357

Descrição

Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4168g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

Palavras-chave

Versões (2)

1. 03/07/2017 03/07/2017 -
2. 25/07/2017 25/07/2017 -

Titular dos direitos

Genentech, Inc.

Transferido a

3 de julho de 2017

DOI

Para um pedido faça login.

Licença